Christopher Peetz
2023
In 2023, Christopher Peetz earned a total compensation of $6.5M as Chief Executive Officer at Mirum Pharmaceuticals, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $633,600 |
|---|---|
| Option Awards | $3,383,920 |
| Salary | $660,000 |
| Stock Awards | $1,761,000 |
| Other | $13,200 |
| Total | $6,451,720 |
Peetz received $3.4M in option awards, accounting for 52% of the total pay in 2023.
Peetz also received $633.6K in non-equity incentive plan, $660K in salary, $1.8M in stock awards and $13.2K in other compensation.
Rankings
In 2023, Christopher Peetz's compensation ranked 65th out of 2,918 executives tracked by ExecPay. In other words, Peetz earned more than 97.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 65 out of 2,918 | 98th |
Division Manufacturing | 32 out of 1,608 | 98th |
Major group Chemicals And Allied Products | 24 out of 901 | 97th |
Industry group Drugs | 23 out of 864 | 97th |
Industry Pharmaceutical Preparations | 16 out of 622 | 97th |
Source: SEC filing on April 23, 2024.
Peetz's colleagues
We found two more compensation records of executives who worked with Christopher Peetz at Mirum Pharmaceuticals in 2023.
News
Mirum Pharmaceuticals CEO Christopher Peetz's 2023 pay jumps 47% to $6.5M
April 23, 2024
Mirum Pharmaceuticals CEO Christopher Peetz's 2022 pay rises 7% to $4.4M
May 1, 2023
Mirum Pharmaceuticals CEO Christopher Peetz's 2021 pay jumps 38% to $4.1M
April 22, 2022
Mirum Pharmaceuticals CEO Christopher Peetz's 2020 pay falls 52% to $3M
April 14, 2021